Nutritional Markers in Normal and Hyperemesis Pregnancies

NCT ID: NCT02619188

Last Updated: 2016-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-09-30

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluate the rate of nausea and nutritional status in patients with hyperemesis gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The Investigators aim for developing normal range of prealbumin measurements (reference values) during first trimester of pregnancy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Women affected with hyperemesis gravidarum are at severe nutritional risk. Reference values for biochemical parameters evaluating nutritional status during early pregnancy needs to be determined.

The investigators will compare clinical nutritional parameters (weight gain/weight loss) with rate of nausea (PUQE-questionnaire), self-reported nutritional intake form and biochemical measurements (prealbumin) in women admitted to hospital with hyperemesis gravidarum and healthy pregnant women.

For hyperemesis patients measurements will be repeated at discharge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperemesis Gravidarum Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hyperemesis gravidarum

Hyperemesis gravidarum patients admitted to hospital PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis), Intervention at discharge : PUQE-form, Nutritional form and Blood sampling

PUQE-form inclusion

Intervention Type OTHER

PUQE-form encompassing last 24 hours completion

Nutritional form inclusion

Intervention Type OTHER

Food-list form encompassing last 24 hours completion

Blood sampling inclusion

Intervention Type OTHER

Measurement of biochemical nutrition marker(s); Prealbumin

Intervention at discharge

Intervention Type OTHER

PUQE-form, nutritional form and Blood sampling

Control: Healthy pregnant women

Outpatients NOT subjected to severe nausea and emesis (PUQE-score \<13). PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis).

PUQE-form inclusion

Intervention Type OTHER

PUQE-form encompassing last 24 hours completion

Nutritional form inclusion

Intervention Type OTHER

Food-list form encompassing last 24 hours completion

Blood sampling inclusion

Intervention Type OTHER

Measurement of biochemical nutrition marker(s); Prealbumin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PUQE-form inclusion

PUQE-form encompassing last 24 hours completion

Intervention Type OTHER

Nutritional form inclusion

Food-list form encompassing last 24 hours completion

Intervention Type OTHER

Blood sampling inclusion

Measurement of biochemical nutrition marker(s); Prealbumin

Intervention Type OTHER

Intervention at discharge

PUQE-form, nutritional form and Blood sampling

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Pregnancy Unique Questionnare of Emesis

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women \< 16 weeks of gestation
* Admitted to hospital for hyperemesis gravidarum (HG group) with nausea and vomiting in pregnancy with at least two of following criteria; weight loss, dehydration, fluid-/electrolyte disturbances, ketonuria

Exclusion Criteria

* Non-viable pregnancy diagnosed at time of inclusion
* Unable to understand Norwegian
* PUQE-score \>= 13 (control group)
* Nausea an vomiting in pregnancy caused by other conditions than Hyperemesis gravidarum
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Bergen

OTHER

Sponsor Role collaborator

Haukeland University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jone Trovik, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Senior consultant

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital

Bergen, Hordaland, Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jone Trovik, MD, PhD

Role: CONTACT

0047 55974200 ext. 4256

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jone Trovik, MD, PhD

Role: primary

55974200 ext. 4256

References

Explore related publications, articles, or registry entries linked to this study.

Birkeland E, Stokke G, Tangvik RJ, Torkildsen EA, Boateng J, Wollen AL, Albrechtsen S, Flaatten H, Trovik J. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study. PLoS One. 2015 Apr 1;10(4):e0119962. doi: 10.1371/journal.pone.0119962. eCollection 2015.

Reference Type BACKGROUND
PMID: 25830549 (View on PubMed)

Stokke G, Gjelsvik BL, Flaatten KT, Birkeland E, Flaatten H, Trovik J. Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: a 10-year retrospective cohort study. Acta Obstet Gynecol Scand. 2015 Apr;94(4):359-67. doi: 10.1111/aogs.12578. Epub 2015 Feb 17.

Reference Type BACKGROUND
PMID: 25581215 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015/894

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glycated Albumin in Pregnancy
NCT03372824 COMPLETED
Prenatal Nutrient Status Study
NCT06156826 COMPLETED